Hyutekan Tablet 8mg (Candesaritan Cilexetil)

Adult dose

1. Essential Hypertension - The recommended starting and maintenance dose is 8 to 16 mg of candesaritan cilexetil taken orally once daily. - If blood pressure is not adequately controlled after 4 weeks of treatment at a dose of 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. - For patients with decreased effective circulating blood volume and renal impairment, the initial dose should be 4 mg, and for patients with liver dysfunction, it should be adjusted to 2 mg once daily. 2.

Child dose

Safety and efficacy for youths and children under 18 years of age have not been established.

This medication can cause serious harm to the fetus and newborn if taken during pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to this medicine or its components, pregnant or nursing women, patients with severe liver impairment, and those with hereditary angioedema should not take this medication. Elderly patients, those with hyperkalemia, patients with liver impairment, heart valve disease, and those with poor kidney function should take this medication with caution, and it is important to monitor potassium and kidney function through regular blood tests. During treatment, side effects such as dizziness, back pain, and respiratory infections may occur, and rarely, serious allergic reactions, renal function deterioration, or blood abnormalities may arise, so consult a doctor immediately if any abnormal symptoms occur. Blood pressure may drop sharply; therefore, patients undergoing dialysis or taking diuretics or antihypertensive medication should start with a small amount and gradually increase the dose at the beginning of treatment. When taken in combination with other antihypertensive medications, this can enhance the blood pressure-lowering effect, so it should be taken as directed by a physician, and when used with specific diuretics, lithium, or non-steroidal anti-inflammatory drugs, kidney function and potassium levels must be monitored carefully. Women planning to become pregnant or who might be pregnant should not take this medication, and it is also advisable to avoid using it while nursing. Safety and efficacy for children and adolescents under 18 years of age have not been established, so it is recommended not to administer it to them. Caution is needed while driving or operating machinery, as dizziness may occur. In case of overdose, symptoms such as symptomatic hypotension, dizziness, and rapid heartbeat may occur, and immediate medical attention is necessary. Keep out of reach of children, and do not transfer to other containers for safety.

Serious side effects

Hives, severe swelling (edema), angioedema (swelling of the face, lips, tongue, throat), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with cough and fever, yellowing of the skin or eyes (jaundice), systemic weakness, sudden and severe headache, lightning.

Mild side effects

Dizziness, back pain, respiratory infections (upper respiratory tract infections, pharyngitis, rhinitis), fatigue, peripheral edema, chest pain, headache, bronchitis, cough, sinusitis, nausea, abdominal pain, diarrhea, vomiting, joint pain, proteinuria, weakness, fever, sensory disturbances, indigestion, gastritis, tachycardia, palpitations, increased creatine kinase, hyperglycemia, hypertriglyceridemia, hyperuricemia, myalgia, nosebleeds, anxiety, depression, drowsiness, rash, increased sweating, hematuria,

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain the storage temperature between 1 to 30 degrees Celsius.

Appearance

Light pink, round tablets with a convex surface on both sides.

Package unit

30 tablets/bottle. 100 tablets/bottle